CryoLife (CRY) Tops Q4 EPS by 3c

Go back to CryoLife (CRY) Tops Q4 EPS by 3c

CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results

February 15, 2017 5:24 PM EST

ATLANTA, Feb. 15, 2017 /PRNewswire/ --

Fourth Quarter Highlights:

Revenues Increased 13 Percent Year-over-Year to $45.0 Million; Non-GAAP Revenues Decreased Two Percent Year-over-Year Gross Margins Increased to 69 Percent; Non-GAAP Gross Margins Increased to 71 Percent GAAP Net Income was $2.9 Million, or $0.09 Per Fully Diluted Common Share; Non-GAAP Net Income was $4.1 Million, or $0.12 Per Fully Diluted Common Share

CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing... More